The hypothalamic-pituitary-adrenal axis in the pathogenesis of rheumatic diseases

Endocrinology and Metabolism Clinics of North America

Volumn 31, Issue 1, 2002, Pages 1-13

  Crofford, Leslie J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; AUTOIMMUNE DISEASE; CELL DEATH; CONTROLLED STUDY; HORMONE RESPONSE; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNOREGULATION; INFLAMMATORY CELL; MEDIATOR RELEASE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVIEW; RHEUMATIC DISEASE; ADRENAL GLAND; ANIMAL; DISEASE MODEL; FEEDBACK SYSTEM; FIBROMYALGIA; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; IMMUNITY; NEUROSECRETION; PATHOPHYSIOLOGY; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADRENAL GLANDS; ANIMAL; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; FEEDBACK; FIBROMYALGIA; HUMAN; HYPOTHALAMUS; IMMUNITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEUROSECRETORY SYSTEMS; PITUITARY GLAND; RHEUMATIC DISEASES; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; HUMANS;

ANIMALIA;

EID: 0036014491     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(01)00004-4     Document Type: Review

References (72)

1. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome
2. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis
3. Corticotropin releasing hormone (CRH) promoter polymorphisms in various ethnic groups of patients wilh rheumatoid arthritis
4. The immune-hypothalamic-pituitary-adrenal axis
5. A molecular basis for bi-directional communication between the immune and neuroendocrine systems
6. Biochemistry and modulation of nociception and pain
7. Stress and the single cytokine: Interleukin modulation of the pituitary-adrenal axis
8. Macrophage inhibitory factor: A glucocorticoid counter-regulator within the immune system
9. A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility
10. Pituitary-adrenal responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low-dose prednisone
11. Reciprocal interactions between the neuroendocrine and immune systems during inflammation
12. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis
13. The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis
14. Neuroendocrine abnormalities in fibromyalgia and related disorders
15. Central modulation of pain perception
16. Evidence that abnormalities of central neurohormonal systems are key to understanding libromyalgia and chronic fatigue syndrome
17. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis
18. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia
19. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis
20. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids
21. Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases
22. Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis
23. Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain)
24. Multipoint linkage analysis of a candidate gene locus in rheumatoid arthritis demonstrates significant evidence of linkage and association with the corticotropin-releasing hormone genomic region
25. Desmopressin and low-dose ACTH test in rheumatoid arthritis
26. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome
27. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain
28. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: A controlled study using insulin hypoglycemia stress test and prolactin stimulation
29. Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus
30. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial pro-opiomelanocortin mRNA during chronic inflammatory stress
31. Differential effects of psychological and immunological challenge on the hypothalamo-pituitary-adrenal axis function in adjuvant-induced arthritis
32. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood
33. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis
34. Stress and rheumatic diseases
35. Neuroendocrine manifestations in Sjögren's syndrome
36. Hypofunction of the stress axis in Sjögren's syndrome
37. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis
38. ACTH glucocorticoid and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: Relations with indices of inflammation
39. Hormonal alterations in rheumatoid arthritis, including the effects of pregnancy
40. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo
41. The biology of interleukin-6
42. Circadian rhythms of women with fibromyalgia
43. Macrophage migration inhibitory factor in rheumatoid arthritis: Evidence of proinflammatory function and regulation by glucocorticoids
44. Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis
45. Hormonal and immunologic risk factors for the development of rheumatoid arthritis: An integrative physiopathogenetic perspective
46. Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis
47. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans
48. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: Potential implications for the syndrome of inappropriate vasopressin secretion
49. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia
50. Involvement of the nuclear orphan receptor NURRI in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis
51. Adrenal secretion in cortisol in patients with rheumatoid arthritis
52. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erethymatosus and other connective tissue diseases
53. Fas/Fas ligand-associated apoptosis in experimental autoimmune uveoretinitis in rodents: Role of proinflammatory corticotropin-releasing hormone
54. The hpothalamic-pituitary response in SLE. Regulation of prolactin, growth hormone, and cortisol release
55. Disrupted 24-hour patterns of cortisol secretion in psychotic depressives
56. Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: Interaction with glucocorticoids
57. Inflammatory disease as chronic stress
58. Alterations in hypothalamic-pituitary-adrenal function correlated with the onset of murine SLE in MRL +/+ and lpr/lpr mice
59. Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man
60. Impact of sleep debt on metabolic and endocrine function
61. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats
62. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats
63. Role of adrenal glucocorticoids in the blockade of analgesic tolerance to morphine by footshock stress exposure in mice
64. Intrinsic mechanisms of pain inhibition: Activation by stress
65. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects
66. Relationship between hypothalamic-pituitary-adrenal activity and lockade of tolerance to morphine analgesia by pain: A strain comparison
67. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: Suppression of pituitary ACTH release and peripheral inflammation
68. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases
69. Hormones and autoimmunity: Animal models of arthritis
70. Neuroendocrine-immune system interactions and autoimmunity
71. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia
72. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor